This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Analysts' Actions: Biomarin, Family Dollar, L Brands, J.M. Smucker


Anixter (AXE) was downgraded at Robert Baird to neutral from outperform. Twelve-month price target is $108. Valuation call, as the stock has outperformed the market over the past two years, Robert Baird said.

Biomarin (BMRN) was upgraded at Credit Suisse to outperform from neutral. Twelve-month price target is $73. Stock has pulled back to an attractive entry point, Credit Suisse said.

Capital One (COF) was upgraded at Nomura to buy from neutral. Twelve-month price target was raised to $94. Loan growth to turn positive this year and low intangible amortization creates a tailwind in 2014, Nomura said.

Dollar General (DG - Get Report) was upgraded at Jefferies to buy from hold. Driven by potential consolidation in the dollar-store space, Jefferies said. Twelve-month price target is $75.

Ecopetrol (EC) was downgraded to hold at TheStreet Ratings.

Family Dollar Stores (FDO) was upgraded at Jefferies to buy from hold. Driven by potential consolidation in the dollar-store space, Jefferies said. Twelve-month price target is $79.

Halcon (HK) was upgraded to hold at TheStreet Ratings.

>>Read More: Five Wins for Guerilla Marketing at the 2014 World Cup

L Brands (LB) was upgraded at Oppenheimer to perform from underperform. Twelve-month price target is $56. Company can continue to expand its brands overseas, Oppenheimer said.

J.M. Smucker (SJM) was upgraded at Wells Fargo to market perform from underperform. M&A potential could drive growth in the coming quarters, Wells Fargo said.

Editor's note: To see analysts' stock comments and changes to price targets and earnings estimates, go to "Street Notes" which is available only to Real Money subscribers. To find out how to become a subscriber, please click here.

Follow TheStreet on Twitter and become a fan on Facebook.

>>Read More: Merck Buys Idenix for $39 Billion in Yet Another Blockbuster Hep C Deal

>>Read More: Twitter Investors Could Still Feel More Pain

This article was written by a staff member of TheStreet.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
FDO $0.00 0.00%
DG $82.19 -0.52%
AAPL $92.10 -1.20%
FB $118.57 0.65%
GOOG $705.13 0.53%


Chart of I:DJI
DOW 17,637.29 -23.42 -0.13%
S&P 500 2,046.02 -4.61 -0.22%
NASDAQ 4,697.1260 -19.9680 -0.42%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs